G1 Therapeutics Widgets and Gadgets
| GTHXDelisted Stock | USD 7.15 0.00 0.00% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GTHX G1 Therapeutics
- Latest GTHX SHAREHOLDER ALERT The MA Class Action Firm Investigates the Tender Offer of G1 Therapeutics, Inc.
- GTHX 7.15 0.0
- Low 7.14
- High 7.16
- Alpha 1.71
- Beta -0.82
- Return On Equity -1.09
- Return On Asset -0.19
- Profit Margin (0.77) %
- Operating Margin (0.21) %
- Current Valuation 364.46 M
- Shares Outstanding 52.76 M
- Shares Owned By Insiders 10.92 %
- Shares Owned By Institutions 54.61 %
- Number Of Shares Shorted 3.41 M
- Price To Earning (1.95) X
- Price To Book 15.34 X
- Price To Sales 6.48 X
- Revenue 82.51 M
- Gross Profit 47.55 M
- EBITDA (39.01 M)
- Net Income (47.97 M)
- Cash And Equivalents 143.96 M
- Cash Per Share 3.37 X
- Total Debt 57.17 M
- Debt To Equity 1.24 %
- Current Ratio 4.75 X
- Book Value Per Share 0.47 X
- Cash Flow From Operations (38.34 M)
- Short Ratio 1.01 X
- Earnings Per Share (0.86) X
- Target Price 7.15
- Number Of Employees 100
- Beta 1.68
- Market Capitalization 377.22 M
- Total Asset 121.54 M
- Retained Earnings (779.99 M)
- Working Capital 85.23 M
- Current Asset 252.33 M
- Current Liabilities 9.86 M
- Net Asset 121.54 M
- Accumulation Distribution 0.0028
- Rate Of Daily Change 1.0
- Day Median Price 7.15
- Day Typical Price 7.15
- Market Facilitation Index 0.02
Market Snapshot Widget Example
DAX Index Germany | 19,626 1.03 | |
Taiwan Weighted Taiwan | 22,262 0.16 | |
PSI 20 Stock Portugal | 6,418 0.2 | |
CROBEX Croatia | 3,162 0.09 | |
Budapest SE Hungary | 77,936 0.56 | |
IDX 30 Jakarta Indonesia | 438.73 2.01 | |
ISEQ 20 Price Ireland | 1,611 1.06 | |
NYSE Comp USA | 20,272 0.31 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,080 2.35 | |
IPC MEXICO Mexico | 49,710 0.21 | |
KL Technology Malaysia | 58.48 0.43 | |
IBEX 35 Index Spain | 11,641 0.26 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,539 0.30 | |
SPASX Dividend Opportunities Australia | 1,697 0.03 | |
HNX 30 Vietnam | 479.79 0.88 | |
Bucharest BET-NG Romania | 1,193 1.43 | |
AMS Small Cap Netherlands | 1,227 1.00 | |
Oslo Exchange Mutual Norway | 1,410 0.22 | |
BEL Small Belgium | 8,012 0.4 | |
Basic Materials Brazil | 5,874 1.78 | |
Swiss Leader Price Switzerland | 1,941 0.51 | |
Fondo Mutuo ETF Chile | 1,367 0.39 | |
Athens General Comp Greece | 1,393 0.74 | |
Stock Exchange Of Thailand | 1,428 0.03 | |
PX Prague Stock Czech Repub | 1,682 0.33 | |
THE PHILIPPINE STOCK Philippines | 6,614 0.37 | |
WIG 30 Poland | 2,809 0.30 | |
BIST Electricity Turkey | 490.89 0.35 |
Investing Ideas
In addition to having G1 Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare G1 Therapeutics
Compare G1 Therapeutics To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in GTHX Stock
If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |